Get the Stockscreener App
22.29
6.91%
-1.655
After Hours:
22.30
0.015
+0.07%
Staar Surgical Co stock is traded at $22.29, with a volume of 7.01M.
It is down -6.91% in the last 24 hours and down -12.19% over the past month.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
See More
Previous Close:
$23.94
Open:
$20
24h Volume:
7.01M
Relative Volume:
5.62
Market Cap:
$1.10B
Revenue:
$224.45M
Net Income/Loss:
$-95.27M
P/E Ratio:
-11.55
EPS:
-1.93
Net Cash Flow:
$-43.74M
1W Performance:
-3.99%
1M Performance:
-12.19%
6M Performance:
+24.78%
1Y Performance:
-4.48%
1-Day Range:
$19.82
$22.59
1-Week Range:
$19.82
$24.26
52-Week Range:
$13.50
$30.81
Staar Surgical Co Stock (STAA) Company Profile
Name
Staar Surgical Co
Sector
Industry
Phone
(626) 303-7902
Address
1911 WALKER AVE, MONROVIA, CA
Compare STAA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
22.29 | 1.18B | 224.45M | -95.27M | -43.74M | -1.93 |
|
ISRG
Intuitive Surgical Inc
|
592.85 | 200.78B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
205.36 | 56.69B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
81.81 | 39.62B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
249.19 | 35.81B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
39.77 | 30.70B | 27.43B | 1.27B | 1.01B | 1.5829 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-25 | Initiated | Wells Fargo | Equal Weight |
| Feb-12-25 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-12-25 | Downgrade | Jefferies | Buy → Hold |
| Feb-12-25 | Downgrade | Mizuho | Outperform → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jun-11-24 | Upgrade | BTIG Research | Neutral → Buy |
| Mar-11-24 | Upgrade | Stifel | Hold → Buy |
| Dec-05-23 | Downgrade | Needham | Buy → Hold |
| Dec-04-23 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-03-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jun-07-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-17-23 | Initiated | Piper Sandler | Neutral |
| Feb-06-23 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-28-22 | Reiterated | BTIG Research | Buy |
| Dec-08-22 | Initiated | Stifel | Hold |
| Nov-07-22 | Upgrade | Sidoti | Neutral → Buy |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-28-22 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-18-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-09-21 | Initiated | Oppenheimer | Perform |
| Jan-19-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Oct-26-20 | Downgrade | Sidoti | Buy → Neutral |
| Aug-31-20 | Upgrade | Sidoti | Neutral → Buy |
| Aug-06-20 | Reiterated | The Benchmark Company | Buy |
| Jul-06-20 | Downgrade | Sidoti | Buy → Neutral |
| Jun-24-20 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-15-20 | Initiated | Jefferies | Buy |
| Dec-04-19 | Initiated | BTIG Research | Buy |
| Sep-24-18 | Reiterated | The Benchmark Company | Buy |
| Aug-06-18 | Resumed | The Benchmark Company | Buy |
| Nov-20-17 | Reiterated | The Benchmark Company | Buy |
| Aug-14-17 | Reiterated | The Benchmark Company | Buy |
| Mar-03-17 | Reiterated | The Benchmark Company | Buy |
| May-18-16 | Upgrade | The Benchmark Company | Hold → Buy |
| Sep-10-13 | Resumed | The Benchmark Company | Buy |
| Feb-28-13 | Reiterated | The Benchmark Company | Buy |
| Nov-01-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-02-12 | Initiated | Northland Securities | Outperform |
| Oct-25-11 | Reiterated | The Benchmark Company | Buy |
| Oct-12-10 | Initiated | Morgan Joseph | Buy |
| May-11-10 | Initiated | Benchmark | Buy |
View All
Staar Surgical Co Stock (STAA) Latest News
STAAR Surgical Merger With Alcon Fails After Shareholders Vote No - Benzinga
Staar Surgical Shareholders Reject $1.6 Billion Merger - Orange County Business Journal
Exclusive: STAAR Surgical deal fails as shareholder support remains at around 30% - Investing.com
Staar Surgical to reject Alcon takeover bid after failing to win shareholder backing - Reuters
STAAR Surgical stock rating reiterated as Neutral by BTIG - Investing.com Nigeria
Needham maintains Hold rating on STAAR Surgical stock after failed acquisition - Investing.com Nigeria
STAAR shareholders reject Alcon acquisition bid - Investing.com
STAAR Surgical (STAA) Shares Drop 19% After Alcon Deal Terminati - GuruFocus
STAAR shareholders reject Alcon acquisition bid By Investing.com - Investing.com UK
STAAR shareholders just rejected a proposed sale of the company to Alcon - Stock Titan
STAAR Surgical Says It Plans to Terminate Merger Deal with Alcon - Medical Product Outsourcing
Staar Surgical to terminate Alcon deal after stockholder vote - MassDevice
STAAR Surgical to remain independent after failed Alcon merger vote By Investing.com - Investing.com India
STAAR Surgical sinks as it plans to terminate sale to Alcon (STAA:NASDAQ) - Seeking Alpha
STAAR Surgical Co Announces Termination of Alcon Merger Agreement - TradingView — Track All Markets
STAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders - Bluefield Daily Telegraph
STAAR Surgical's proposed merger with Alcon falls through as shareholders reject the deal - Bitget
STAAR Surgical (STAA) Faces Potential Delay in Alcon (ALC) Acqui - GuruFocus
STAAR Surgical vote on Alcon may be delayed againreport - Seeking Alpha
Is STAAR Surgical Company a good long term investmentDividend Growth Stocks & Breakthrough Stock Performance - earlytimes.in
The Truth About STAAR Surgical Co: Tiny Eye Stock With Massive Upgrade Energy - AD HOC NEWS
Midday Stock Roundup: Rivian Down on Production Totals - Orange County Business Journal
New $17 Million Bet on STAAR Surgical Comes as Sales Jump 7% and Margins Hit 82% - The Globe and Mail
Midday Stock Roundup: Shimmick Corp. climbs 14% - Orange County Business Journal
What a $22 Million Bet on STAAR Surgical Signals After Third-Quarter Earnings and a 15% Market Lag - The Motley Fool
STAAR Surgical’s special meeting postponed again amid shareholder opposition By Investing.com - Investing.com Nigeria
STAAR Shareholder Vote Delayed for Fourth Time - Medical Device and Diagnostic industry
Exclusive: STAAR merger with Alcon still fails to gain traction, only 30% vote for - Investing.com Australia
STAAR Surgical’s special meeting postponed again amid shareholder opposition - Investing.com
STAAR Surgical (STAA) Rises Amid Adjourned Shareholder Vote on A - GuruFocus
Big STAAR shareholder fights yet another delay on sale to Alcon - Stock Titan
Midday Stock Roundup: Rivian Stock Continues to Climb - Orange County Business Journal
Alcon Exercises Right To Require STAAR Surgical To Adjourn Its Special Meeting Of Stockholders - TradingView — Track All Markets
Eye implant maker delays shareholder vote on merger with Alcon - Stock Titan
Using the ICL as a supplementary IOL - EyeWorld
Will STAAR Surgical Company stock reach all time highs in 2025Trade Volume Summary & High Yield Stock Recommendations - ulpravda.ru
STAAR Surgical (NASDAQ:STAA) Shares Down 5.1%What's Next? - MarketBeat
Broadwood urges STAAR Surgical shareholders to vote against Alcon transaction - MSN
Broadwood sees $50/share path for STAAR Surgical as merger battle nears voting day - Investing.com India
Defender Capital to vote against STAAR Surgical sale to Alcon By Investing.com - Investing.com Nigeria
Defender Capital to vote against STAAR Surgical sale to Alcon - Investing.com
STAAR Surgical (NASDAQ: STAA) faces Broadwood campaign against Alcon deal and for board shake-up - Stock Titan
STAAR urges stockholders to vote for Alcon merger amid proxy battle - Investing.com Nigeria
Broadwood urges shareholders to reject Alcon’s bid for STAAR - Investing.com
Broadwood urges Staar Surgical shareholders to vote against Alcon transaction - TipRanks
Big STAAR investor fights Alcon buyout, says shares should hit $50 - Stock Titan
STAAR Stockholders Have a Choice: Vote FOR Alcon’s Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value | ALC Stock News - Stock Titan
Yunqi Capital Comments on Proxy Advisors' Updated Recommendations, Urges Shareholders to Continue to Back the Company's Standalone Trajectory - marketscreener.com
STAAR Surgical (NASDAQ: STAA) faces proxy fight over Alcon merger bid - Stock Titan
Yunqi Capital opposes Alcon deal for STAAR Surgical (NASDAQ: STAA) at $30.75 - Stock Titan
ISS recommends STAAR Surgical deal, but warns shareholders have reason to object - Investing.com
Staar Surgical Co Stock (STAA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Staar Surgical Co Stock (STAA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Nov 20 '25 |
Buy |
27.14 |
393,382 |
10,675,325 |
14,222,005 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Nov 19 '25 |
Buy |
26.42 |
309,132 |
8,166,155 |
13,828,623 |
| Jiang Wei | Director |
Nov 12 '25 |
Option Exercise |
0.00 |
20,967 |
0 |
45,477 |
| Jiang Wei | Director |
Aug 12 '25 |
Option Exercise |
0.00 |
20,967 |
0 |
24,510 |
4.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):